Bamco Inc. NY Boosts Position in Sientra Inc (SIEN)
Bamco Inc. NY increased its position in shares of Sientra Inc (NASDAQ:SIEN) by 6.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 501,500 shares of the medical instruments supplier’s stock after buying an additional 30,000 shares during the quarter. Bamco Inc. NY owned 2.59% of Sientra worth $7,723,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of SIEN. JPMorgan Chase & Co. bought a new position in Sientra in the second quarter valued at approximately $101,000. Nationwide Fund Advisors grew its stake in Sientra by 260.4% in the second quarter. Nationwide Fund Advisors now owns 10,963 shares of the medical instruments supplier’s stock valued at $107,000 after purchasing an additional 7,921 shares in the last quarter. New York State Common Retirement Fund bought a new position in Sientra in the second quarter valued at approximately $148,000. Rhumbline Advisers bought a new position in Sientra in the second quarter valued at approximately $158,000. Finally, Dimensional Fund Advisors LP grew its stake in Sientra by 23.4% in the second quarter. Dimensional Fund Advisors LP now owns 18,660 shares of the medical instruments supplier’s stock valued at $181,000 after purchasing an additional 3,534 shares in the last quarter. Institutional investors and hedge funds own 76.63% of the company’s stock.
SIEN has been the subject of a number of analyst reports. BidaskClub downgraded Sientra from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Canaccord Genuity restated a “buy” rating and issued a $14.00 price target on shares of Sientra in a research note on Sunday, October 8th. William Blair upgraded Sientra from a “market perform” rating to an “outperform” rating in a research note on Wednesday, September 13th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a $14.00 price objective (up from $11.00) on shares of Sientra in a research report on Wednesday, September 27th. Two analysts have rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company’s stock. Sientra has an average rating of “Hold” and a consensus target price of $13.75.
Sientra (NASDAQ:SIEN) last released its quarterly earnings data on Tuesday, November 7th. The medical instruments supplier reported ($0.74) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.68) by ($0.06). Sientra had a negative net margin of 169.77% and a negative return on equity of 68.82%. The business had revenue of $9.80 million during the quarter, compared to analyst estimates of $10.54 million. During the same period in the previous year, the business earned ($0.55) earnings per share. The business’s quarterly revenue was up 50.8% on a year-over-year basis. equities analysts anticipate that Sientra Inc will post -3.24 EPS for the current fiscal year.
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.